Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial
-
Published:2023-05-30
Issue:4
Volume:26
Page:812-812
-
ISSN:1365-7852
-
Container-title:Prostate Cancer and Prostatic Diseases
-
language:en
-
Short-container-title:Prostate Cancer Prostatic Dis
Author:
Ohlmann Carsten-HenningORCID,
Jäschke Michelle,
Jaehnig Peter,
Krege Susanne,
Gschwend Jürgen,
Rexer Heidrun,
Junker Kerstin,
Zillmann Roger,
Rüssel Christoph,
Hellmis Eva,
Suttmann Henrik,
Janssen Martin,
Marin Jan,
Hübner Andreas,
Mathers Michael,
Gleißner Jochen,
Scheffler Michael,
Feyerabend Susan,
Telle Jens,
Klier Jörg,
Stöckle Michael
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology